N/A N=52 Low-Frequency, High-Intensity Ultrasound for Waist Circumference Reduction
Abdominal Subcutaneous Fat
Primary: Waist Circumference Change — -2.03 Inches
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=70 SlimShape Device for Abdominal Fat and Circumference Reduction
Fat Disorder
Primary: Change in Fat Thickness at Final Follow-up Compared to Baseline — -1.76 millimeters
N/A N=62 UltraShape Power for Abdominal Fat and Circumference Reduction
Excess Abdominal Fat
Primary: Change in Abdominal Fat Thickness Compared to Baseline as Measured by Ultrasound — -10.5 percentage change
N/A N=54 Study of Low Level Laser Light Therapy on Circumference Reduction
Circumference Reduction
Primary: Change in Combined Circumference Measurements — -5.36 inches — p=<.0001
N/A N=70 Pivotal Study of the truSculpt Radiofrequency Device for Circumferential Reduction
Abdominal Fat
Primary: Difference in Circumferential Measurement Related to Sham and Therapeutic Group at 12 Weeks Post-treatment — 1.9; 0 cm
N/A N=60 Non-Invasive Reduction of Abdominal Fat
Fat Reduction
Primary: Proportion of Pre-treatment Images Correctly Identified — 128 photos — p=<0.001
N/A N=53 Study of Low Level Laser Therapy to Reduce Body Circumference in Obese Individuals
Obesity
Primary: Difference in the Proportion of Primary Outcome Successes Between Treatment Groups for Change in Combined Circumference Measurements — 20; 3 participants — p=<0.00005
N/A N=75 Trim II for Noninvasive Lipolysis and Circumference Reduction of Abdomen.
Circumference Reduction of Abdomen
Primary: Evaluation of Change in Abdomen Circumference Using Tape Measurements in cm at the 3 Months Follow-up Visit Comparing to Baseline. — 89.5 CM
N/A N=44 The Trusculpt (Radio Frequency) Device For Thigh Circumference Reduction
Body Fat
Primary: Change of Thigh Circumference From Baseline — .98; .32 cm
N/A N=16 VelaShape III & UltraShape Power for Thigh Circumference Reduction
Circumference Reduction
Primary: Circumference Change in the Thighs at the 12-week Follow-up Compared to Baseline Measurements — -2.8 centimeter
N/A N=81 Efficacy and Safety of the BeShape One Device for Non-invasive Waist Circumference Reduction
Dermatological Non-Disease
Primary: Change in Waist Circumference — -1.87 cm — p=<0.0001
N/A N=60 Effects of Electrical Muscle Stimulation on Waist Circumference in Adults
Abdominal Obesity
Primary: Waist Circumference — 87.0; 89.4 cm
N/A N=20 CoolSculpting in the Abdomen Using Applicator With and Without CCI
Body Fat Disorder
Primary: Percentage of Accurately Identified Pre-treatment Photos — 33; 23; 50; 23 photos
N/A N=60 LLLT for Reducing Waste Circumference and Weight
Weight Loss
Primary: Change in Weight — -0.5; -0.9; -0.6 Kg — p=0.723
N/A N=25 Non-Invasive Reduction of Fat in the Flanks of Patients With Sharp Body Curvature
Body Fat Disorder
Primary: Safety of the Zeltiq System for Non-invasive Fat Reduction in Subjects With Greater Flank Curvature. — 0; 0 UADEs
N/A N=45 Non-Invasive Reduction of Fat in the Inner Thighs
Body Fat Disorder
Primary: Percentage of Pre-Treatment Images Correctly Identified by Reviewers — 90.5 percentage of correct identifications
N/A N=15 DualSculpting the Abdomen Using CoolSculpting
Body Fat Disorder
Primary: Proportion of Correctly Identified Photos by Blinded Reviewers — 28 photos
N/A N=62 Efficacy Study of the Effect of Low Level Laser Light Therapy on Reducing Upper Arm Circumference
Body Contouring
Primary: Change in Combined Upper Arm Circumference Measurements From Baseline to Endpoint — 18; 1 participants
N/A N=19 Fat Layer Reduction in the Lateral Thighs Using CoolSculpting
Body Fat Disorder
Primary: Safety of the Zeltiq CoolSculpting System in the Outer Thighs — 8; 0 events
Phase 4 N=110 CoolSculpting® Elite for Non-Invasive Fat Reduction
Non-invasive Fat Reduction
Primary: Percentage of Participants With "Satisfied" or "Very Satisfied" on Item #1 for the CSQ (Cryolipolysis Satisfaction Questionnaire) - Midsection — 83.3 percentage of…
N/A N=60 Subcutaneous Fat Reduction in the Submental Area
Body Fat Disorder
Primary: Safety of CoolScupting in the Submental Area — 4 incidence of device- and/or procedure AE
N/A N=40 Feasibility Study of a Belt Applicator
Body Fat Disorder
Primary: Change in the Fat Layer of the Treated Area as Measured by Ultrasound The Change in Fat Layer Thickness in the Treated Outer Thigh — -0.25 cm
N/A N=12 Performance Evaluation of the truSculpt Radiofrequency Device for Lipolysis of Abdominal Fat
Body Fat
Primary: Number of Participants Who's Abdominal Tissue Showed Necrosis or Inflammatory Immune Cell Response — 10; 0 Participants
Phase 3 N=793 Evaluating the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging Due to Subcutaneous Fat (AbCONTOUR2)
Central Abdominal Bulging
Primary: Percentage of Subjects Who Achieved a Composite P-GAPS1/CPnS2 Response — 37; 48 Participants — p=0.397
N/A N=45 CoolSculpting of the Flank With Alternate Treatment Parameters
Body Fat Disorder
Primary: The Number of Device and/or Procedure-Related Adverse Events — 12 device or procedure-related AEs
N/A N=81 Effects of Different Surgical Methods to Treat Obesity
Obesity · Type 2 Diabetes · Insulin Sensitivity
Primary: Insulin Sensitivity at 2 Years — 6.7; 6.6 glucose/kg body weight/min
N/A N=35 CoolSculpting System
Body Fat Disorder
Primary: Percentage of Photographs Correctly Identified by At Least 2 of 3 Blinded Reviewers From the Independent Physician Reviewer Panel — 75.0 % of images identified correctly
N/A N=60 Treatment of Subcutaneous Adipose Tissue in the Thighs Using High Intensity Focused Ultrasound
Treatment of Adipose Tissue in the Thighs
Primary: Clinical Improvement in Thigh Circumference — -1.22; -0.59 centimeter
N/A N=50 CoolSculpting and EMS for the Abdomen
Body Fat Disorder
Primary: Number of Unanticipated Adverse Device Effects (UADE) — 0; 0; 0; 0 events
N/A N=15 Pilot Study on The Flanks of Asian Patients
Body Fat Disorder
Primary: Proportion of Pre-treatment Images Correctly Identified — 32 photos